Omalizumab in severe asthma and food allergies with <scp>IgE</scp> levels >1500 <scp>kU</scp>/L: <scp>Two‐year</scp> evaluation
Giulio Dinardo, Arianna Cafarotti, Francesca Galletta, Alessandro Fiocchi, Stefania Arasi
Abstract
Table S1. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Topics & Concepts
MedicineOmalizumabAsthmaTable (database)Immunoglobulin EFood allergyAllergyFood scienceTable of contentsAdvertisingImmunologyWorld Wide WebAntibodyDatabaseComputer scienceChemistryBusinessAsthma and respiratory diseasesFood Allergy and Anaphylaxis ResearchUrticaria and Related Conditions